Search research articles
Contact Us
Filters
Showing results (341-350 of 371) with videos related to
Page
of 38
Sort By:
Liver International : Official Journal of the International Association for the Study of the Liver
|
October 27, 2022
A phase 2, open-label, randomized, multiple-dose study evaluating Inarigivir in treatment-naïve patients with chronic hepatitis B
Man-Fung Yuen, Chi-Yi Chen, Chun-Jen Liu, et al.
The American Journal of Gastroenterology
|
August 10, 2023
Long-Term Treatment With Tenofovir Alafenamide for Chronic Hepatitis B Results in High Rates of Viral Suppression and Favorable Renal and Bone Safety
Henry L Y Chan, Maria Buti, Young-Suk Lim, et al.
The Lancet. Gastroenterology & Hepatology
|
April 14, 2017
Tenofovir alafenamide versus tenofovir disoproxil fumarate for the treatment of patients with HBeAg-negative chronic hepatitis B virus infection: a randomised, double-blind, phase 3, non-inferiority trial
Maria Buti, Edward Gane, Wai Kay Seto, et al.
Genome Research
|
February 28, 2019
Orientation-aware plasma cell-free DNA fragmentation analysis in open chromatin regions informs tissue of origin
Kun Sun, Peiyong Jiang, Suk Hang Cheng, et al.
The New England Journal of Medicine
|
November 17, 2015
Sofosbuvir and Velpatasvir for HCV Genotype 1, 2, 4, 5, and 6 Infection
Jordan J Feld, Ira M Jacobson, Christophe Hézode, et al.
The Lancet. Gastroenterology & Hepatology
|
February 24, 2020
Switching from tenofovir disoproxil fumarate to tenofovir alafenamide in virologically suppressed patients with chronic hepatitis B: a randomised, double-blind, phase 3, multicentre non-inferiority study
Pietro Lampertico, Maria Buti, Scott Fung, et al.
Nature Communications
|
December 10, 2022
The establishment of COPD organoids to study host-pathogen interaction reveals enhanced viral fitness of SARS-CoV-2 in bronchi
Louisa L Y Chan, Danielle E Anderson, Hong Sheng Cheng, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
November 6, 2013
Noninvasive detection of cancer-associated genome-wide hypomethylation and copy number aberrations by plasma DNA bisulfite sequencing
K C Allen Chan, Peiyong Jiang, Carol W M Chan, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
January 24, 2016
Critical Role of Antimicrobial Peptide Cathelicidin for Controlling Helicobacter pylori Survival and Infection
Lin Zhang, William K K Wu, Richard L Gallo, et al.
JHEP Reports : Innovation in Hepatology
|
September 29, 2023
Tenofovir alafenamide and tenofovir disoproxil fumarate reduce incidence of hepatocellular carcinoma in patients with chronic hepatitis B
Young-Suk Lim, Henry L Y Chan, Sang Hoon Ahn, et al.
Page
of 38
Search research articles
Search
Showing results (341-350 of 371) with videos related to
Sort By:
Page
of 38
Liver International : Official Journal of the International Association for the Study of the Liver
|
October 27, 2022
A phase 2, open-label, randomized, multiple-dose study evaluating Inarigivir in treatment-naïve patients with chronic hepatitis B
Man-Fung Yuen, Chi-Yi Chen, Chun-Jen Liu, et al.
The American Journal of Gastroenterology
|
August 10, 2023
Long-Term Treatment With Tenofovir Alafenamide for Chronic Hepatitis B Results in High Rates of Viral Suppression and Favorable Renal and Bone Safety
Henry L Y Chan, Maria Buti, Young-Suk Lim, et al.
The Lancet. Gastroenterology & Hepatology
|
April 14, 2017
Tenofovir alafenamide versus tenofovir disoproxil fumarate for the treatment of patients with HBeAg-negative chronic hepatitis B virus infection: a randomised, double-blind, phase 3, non-inferiority trial
Maria Buti, Edward Gane, Wai Kay Seto, et al.
Genome Research
|
February 28, 2019
Orientation-aware plasma cell-free DNA fragmentation analysis in open chromatin regions informs tissue of origin
Kun Sun, Peiyong Jiang, Suk Hang Cheng, et al.
The New England Journal of Medicine
|
November 17, 2015
Sofosbuvir and Velpatasvir for HCV Genotype 1, 2, 4, 5, and 6 Infection
Jordan J Feld, Ira M Jacobson, Christophe Hézode, et al.
The Lancet. Gastroenterology & Hepatology
|
February 24, 2020
Switching from tenofovir disoproxil fumarate to tenofovir alafenamide in virologically suppressed patients with chronic hepatitis B: a randomised, double-blind, phase 3, multicentre non-inferiority study
Pietro Lampertico, Maria Buti, Scott Fung, et al.
Nature Communications
|
December 10, 2022
The establishment of COPD organoids to study host-pathogen interaction reveals enhanced viral fitness of SARS-CoV-2 in bronchi
Louisa L Y Chan, Danielle E Anderson, Hong Sheng Cheng, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
November 6, 2013
Noninvasive detection of cancer-associated genome-wide hypomethylation and copy number aberrations by plasma DNA bisulfite sequencing
K C Allen Chan, Peiyong Jiang, Carol W M Chan, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
January 24, 2016
Critical Role of Antimicrobial Peptide Cathelicidin for Controlling Helicobacter pylori Survival and Infection
Lin Zhang, William K K Wu, Richard L Gallo, et al.
JHEP Reports : Innovation in Hepatology
|
September 29, 2023
Tenofovir alafenamide and tenofovir disoproxil fumarate reduce incidence of hepatocellular carcinoma in patients with chronic hepatitis B
Young-Suk Lim, Henry L Y Chan, Sang Hoon Ahn, et al.
Page
of 38